Compare
February 22, 2025
2025-02-22 23:41
Compare
| Saxenda Inj. remove | | |
|---|
| Name | Saxenda Inj. remove | | |
| Image |  | | |
| SKU | FM-07-75794 | | |
| Rating | | | |
| Price | $109.00 | | |
| Stock | 995 in stock
| | |
| Availability | 995 in stock | | |
| Add to cart |
| | |
| Description | | | |
| Content | Indications and Usage
Saxenda® (liraglutide) injection 3 mg is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in:
- Adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (eg, hypertension, type 2 diabetes mellitus, or dyslipidemia)
- Pediatric patients aged 12 years and older with body weight above 60 kg (132 lbs) and initial BMI corresponding to 30 kg/m2 or greater for adults (obese) by international cut-offs
Limitations of Use
- Saxenda® contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist.
- The safety and effectiveness of Saxenda® in pediatric patients with type 2 diabetes have not been established.
- The safety and effectiveness of Saxenda® in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.
| | |
| Weight | N/A | | |
| Dimensions | N/A | | |
| Additional information |
| | |
